1Steinman RM,CohnZA. Identification of a novel cell type in perpheral lymphoid organs of mice. I morphology, quantitation, tissue distribution [J]. Exp Med, 1973,137 (5) : 1142. 被引量：1
2Schott M ,Seissler J. Dendritic cell vaccination., new hope for the treatment of metastasized endorine malignancies [J]. Trends Endocrinol Metab , 2003,14 (4):156-162. 被引量：1
3Seinman RM. The dendritic cell system and its role in immunogenicity [J]. Ammu Rev Immunol, 1991,9:271-296. 被引量：1
4Bubenink J. Genetically engineered dendritic cell-based cancer vaccines [J]. Int J Oncol, 2001,18:475-478. 被引量：1
5Schreurs MW, Eggert AA, Boer A J, et al. Dendritic cells break tolenance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model [J]. Cancer Res. , 2000, 60:6995-7001. 被引量：1
8Ishigami S, Ailou T, Natsugoe S, et al. Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer [J]. Oncology, 1998,55(1):65-69. 被引量：1
9Van den Broeke LT, Daschbach E, Thomas EK, et al. Dendritic cell induced activation of adaptive and innate aniturnor immunity [J]. J Imrnunol, 2003(11):5842-5852. 被引量：1
10Byme SN Ha lliday GM . Dendritic cells : Making progress with tumor regression [J]. Immunol Cell Biol,2002, 80(6):520-530. 被引量：1
二级参考文献19
1Seiter S, Marincola FM. The multiple ways to tumor torlerance. Mod Asp Immunobiol, 2000, 1(3):121 被引量：1
2Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol, 2000, 18:767 被引量：1
3Gabrilovich DI, Chen HL, Girgis KR et al. Production of vascular endothelial growth factor by tumors inhibits the functional maturation of dendritic cells. Nat Med, 1996, 2:1096 被引量：1
4Lespagnard L, Gancberg D, Rouas G, et al. Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: A study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome.Int J Cancer, 1999, 84(3):309 被引量：1
5Chaux P, Favre N, Martin M, et al. Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats. Int J Cancer, 1997, 72(4):619 被引量：1
6Mackey FM, Gunn JR, Maliszewski C, et al. Cutting edge: Dendritic cells require maturation via CD40 to generate protective antitumor immunity. J Immunol, 1998, 161:2094 被引量：1
7Toes REM, Ossendrop F, Offringa R, et al. CD40+ T cells and theri role in antitumor immune responses. J Exp Med, 1998, 189(5):753 被引量：1
8Adler AJ, Marsh DW, Yochum GS, et al. CD4+ T cell tolerance to parechymale self-antigens requirs presentation by bone marrow-derived antigen-presenting cells. J Exp Med, 1998, 187(10):1555 被引量：1
9Matsui S, Ahlers JD, Vortmeyer AO, et al. A model for CD8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4+ T cells through an effect on quality of CTL. J Immunol, 1999, 165:184 被引量：1
10Chai JG, Vendetti S, Amofah E et al. CD152 ligtation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation.J Immunol, 2000, 165(6):3037 被引量：1
